• Vikas Kumar
• March 13, 2023
• HEALTHCARE, NEWS
• Abbott, Bayer AG, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Exelixis Inc., Merck & Co. Inc., Neoplasm Treatment, Neoplasm Treatment Market, Neoplasm Treatment Market analysis, Neoplasm Treatment Market forecast, Neoplasm Treatment Market growth, Neoplasm Treatment Market opportunities, Neoplasm Treatment Market share, Neoplasm Treatment Market size, Neoplasm Treatment Market trend, Novartis AG, Siemens Healthcare GmbH, Teva Pharmaceutical Industries Ltd, Thermo Fisher Scientific
• 0 Comments

A neoplasm is an abnormal growth of cells in the body. It can be a small, non-cancerous growth or it can also be a cancerous or precancerous tumor. A malignant neoplasm can spread to other parts of the body. The rising prevalence of cancer and benign tumors are important factors that drive the market growth of neoplasm treatment. For instance, …